Criminalizes manufacture, sale, and possession of substances containing kratom.
Impact
If enacted, A2642 would amend New Jersey's controlled dangerous substances law, categorizing kratom as a controlled substance with strict penalties. For possession of one ounce or more, individuals could face a second-degree crime charge, which carries penalties of five to ten years in prison and fines up to $150,000. Possession of less than an ounce would be classified as a third or fourth-degree crime, each with respective penalties of up to five years in prison and fines ranging from $10,000 to $15,000. This legislation would have a notable impact on law enforcement and public health, potentially affecting those who use kratom recreationally or for self-medication.
Summary
A2642 is a bill introduced in New Jersey that seeks to criminalize the manufacture, possession, and sale of products containing kratom, a botanical substance derived from a tree native to Southeast Asia. The bill addresses concerns surrounding kratom's psychoactive and opioid-like effects, which have led to its marketing for pain relief and as a potential treatment for addiction to stronger opioids. Despite these claims, the FDA has not approved kratom for any medical use, citing significant health risks, including possible toxicity and dependence.
Contention
The bill has sparked debates regarding public health versus personal freedom. Proponents argue that the lack of regulation and the health risks associated with kratom necessitate its ban to protect citizens from potential harm. Conversely, opponents raise concerns about the criminalization of a substance that some individuals claim provides relief for various ailments. There is a particular concern among advocates for drug policy reform that such measures disproportionately penalize users rather than addressing underlying substance abuse issues and that it may limit access for those who use kratom responsibly.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25